Novo Nordisk的董事和董事长在与控股股东发生战略争议后辞职。 Novo Nordisk's chair and board directors resign after a strategic dispute with the controlling shareholder.

根据熟悉此事的消息来源,Novo Nordisk的董事长和几位独立董事会董事在与公司控股股东发生战略分歧后正在下台。 Novo Nordisk's chair and several independent board directors are stepping down following a strategic disagreement with the company's controlling shareholder, according to sources familiar with the matter. 尽管争议的具体细节尚未披露,但这次撤离标志着领导层在公司长期方向上出现紧张状态的情况下发生了重大转变。 The departure marks a significant leadership shift amid tensions over the firm’s long-term direction, though specific details of the dispute remain undisclosed. 该公司没有公开评论这些变化。 The company has not commented publicly on the changes.